1. Home
  2. PDEX vs MDWD Comparison

PDEX vs MDWD Comparison

Compare PDEX & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pro-Dex Inc.

PDEX

Pro-Dex Inc.

HOLD

Current Price

$72.89

Market Cap

197.4M

Sector

Health Care

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$13.59

Market Cap

181.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDEX
MDWD
Founded
1978
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.4M
181.1M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
PDEX
MDWD
Price
$72.89
$13.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$56.00
$36.00
AVG Volume (30 Days)
62.5K
112.1K
Earning Date
05-01-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
54.31
N/A
EPS
4.12
N/A
Revenue
$77,548,000.00
N/A
Revenue This Year
$7.22
$48.92
Revenue Next Year
N/A
$35.04
P/E Ratio
$17.60
N/A
Revenue Growth
16.45
N/A
52 Week Low
$23.52
$12.52
52 Week High
$77.00
$20.03

Technical Indicators

Market Signals
Indicator
PDEX
MDWD
Relative Strength Index (RSI) 60.59 53.17
Support Level $56.35 $12.52
Resistance Level $77.00 $14.07
Average True Range (ATR) 4.29 0.52
MACD 0.90 0.06
Stochastic Oscillator 78.30 70.80

Price Performance

Historical Comparison
PDEX
MDWD

About PDEX Pro-Dex Inc.

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: